UCB Launches Ra Drug Study Zacks.com Abbott Labs (ABT) markets Humira as a treatment for RA, psoriatic arthritis (PA), ankylosing spondylitis (AS), CD, plaque psoriasis , and juvenile idiopathic arthritis. spell Cimzia is currently marketed by UCB as type A treatment for moderate-to-severe ... and more » Link To Article
No comments:
Post a Comment